Newscenter Media News The ‘reactome’, an AI-powered platform developed by Cambridge and Pfizer, revolutionizes drug design by accurately predicting chemical reactions, streamlining the pharmaceutical development process. Researchers have…
Check Also
SpaceX to launch more private astronaut missions to ISS
SpaceX has signed a deal to fly two more private astronaut missions to the International …